CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

J&J INNOVATIVE MEDICINE recalls IMAAVY (nipocalimab-aahu) Injection

Read the official FDA notice

Published
14 Oct 2026
Units affected
49 vials
Agency
FDA
Country
United States

The hazard

Presence of particulate matter.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

IMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, For Intravenous Infusion After Dilution, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044. NDC: 57894-800-01

Brand / company
J&J INNOVATIVE MEDICINE
Codes / lots
Lot JNYJ1208; Exp. 10/30/2027
Distribution
OH
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 14 Oct 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.